Effect of Combined Perftoran and Indocyanine Green-Photodynamic Therapy on HypoxamiRs and OncomiRs in Lung Cancer Cells

Overview

Journal Front Pharmacol

Date 2022 Apr 4

PMID 35370727

Authors

Amira M Gamal-Eldeen

Amani A Alrehaili

Afaf Alharthi

Bassem M Raafat

Affiliations

Soon will be listed here.

Abstract

Indocyanine green (ICG) is a nontoxic registered photosensitizer used as a diagnostic tool and for photodynamic therapy (PDT). Hypoxia is one the main factors affecting PDT efficacy. Perfluorodecalin emulsion (Perftoran) is a known oxygen carrier This study investigated the effect of Perftoran on ICG/PDT efficacy in presence and absence of Perftoran evaluation of phototoxicity by MTT; hypoxia estimation by pimonidazole, HIF-1/ by ELISA, and 17 miRNAs (tumor suppressors, oncomiRs, and hypoxamiRs) were analyzed by qPCR. Compared to ICG/PDT, Perftoran/ICG/PDT led to higher photocytotoxicity, inhibited pimonidazole hypoxia adducts, inhibited HIF-1/ concentrations, induced the expression of tumor-suppressing miRNAs let-7b/d/f/g, and strongly inhibited the pro-hypoxia miRNA let-7i. Additionally, Perftoran/ICG/PDT suppressed the expression of the oncomiRs miR-155, miR-30c, and miR-181a and the hypoxamiRs miR-210 and miR-21 compared to ICG/PDT. In conclusion, Perftoran induced the phototoxicity of ICG/PDT and inhibited ICG/PDT-hypoxia suppressing HIF-/, miR-210, miR-21, let-7i, miR-15a, miR-30c, and miR-181a and by inducing the expression of let-7d/f and miR-15b.

Citing Articles

Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer.

Sweef O, Zaabout E, Bakheet A, Halawa M, Gad I, Akela M Pharmaceutics. 2023; 15(8).

PMID: 37631277 PMC: 10459057. DOI: 10.3390/pharmaceutics15082061.

References

Ercin M, Bozdogan O, Cavusoglu T, Bozdogan N, Atasoy P, Kocak M . Hypoxic Gene Signature of Primary and Metastatic Melanoma Cell Lines: Focusing on HIF-1β and NDRG-1. Balkan Med J. 2019; 37(1):15-23. PMC: 6934014. DOI: 10.4274/balkanmedj.galenos.2019.2019.3.145. View

Xing L, Su J, Guarnera M, Zhang H, Cai L, Zhou R . Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules. Clin Cancer Res. 2015; 21(2):484-9. PMC: 4299920. DOI: 10.1158/1078-0432.CCR-14-1873. View

Ishizawa T, Fukushima N, Shibahara J, Masuda K, Tamura S, Aoki T . Real-time identification of liver cancers by using indocyanine green fluorescent imaging. Cancer. 2009; 115(11):2491-504. DOI: 10.1002/cncr.24291. View

Young L, Jaffe C, Revkin J, McNULTY P, Cleman M . Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty. Am J Cardiol. 1990; 65(15):986-90. DOI: 10.1016/0002-9149(90)91001-m. View

Oinuma T, Nakamura T, Nishiwaki Y . Report on the National Survey of Photodynamic Therapy (PDT) for Gastric Cancer in Japan (a secondary publication). Laser Ther. 2016; 25(2):87-98. PMC: 4961674. DOI: 10.5978/islsm.16-OR-06. View

Rapoport N, Nam K, Gupta R, Gao Z, Mohan P, Payne A . Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J Control Release. 2011; 153(1):4-15. PMC: 3133819. DOI: 10.1016/j.jconrel.2011.01.022. View

Busch T, Hahn S, Wileyto E, Koch C, Fraker D, Zhang P . Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients. Clin Cancer Res. 2004; 10(14):4630-8. DOI: 10.1158/1078-0432.CCR-04-0359. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Movafagh S, Crook S, Vo K . Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate. J Cell Biochem. 2014; 116(5):696-703. DOI: 10.1002/jcb.25074. View

10.

Schaafsma B, Mieog J, Hutteman M, van der Vorst J, Kuppen P, Lowik C . The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011; 104(3):323-32. PMC: 3144993. DOI: 10.1002/jso.21943. View

11.

Hubaux R, Becker-Santos D, Enfield K, Lam S, Lam W, Martinez V . MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer. Metabolomics (Los Angel). 2014; 2(3):1000108. PMC: 4159950. DOI: 10.4172/2153-0769.1000108. View

12.

Seijo L, Peled N, Ajona D, Boeri M, Field J, Sozzi G . Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. J Thorac Oncol. 2018; 14(3):343-357. PMC: 6494979. DOI: 10.1016/j.jtho.2018.11.023. View

13.

Luo Z, Zheng M, Zhao P, Chen Z, Siu F, Gong P . Self-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic Therapy. Sci Rep. 2016; 6:23393. PMC: 4796897. DOI: 10.1038/srep23393. View

14.

Tsuda T, Kaibori M, Hishikawa H, Nakatake R, Okumura T, Ozeki E . Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma. PLoS One. 2017; 12(8):e0183527. PMC: 5578495. DOI: 10.1371/journal.pone.0183527. View

15.

Abd-Aziz N, Kamaruzman N, Poh C . Development of MicroRNAs as Potential Therapeutics against Cancer. J Oncol. 2020; 2020:8029721. PMC: 7378626. DOI: 10.1155/2020/8029721. View

16.

El-Daly S, Gamal-Eldeen A, Abo-Zeid M, Borai I, Wafay H, Abdel-Ghaffar A . Photodynamic therapeutic activity of indocyanine green entrapped in polymeric nanoparticles. Photodiagnosis Photodyn Ther. 2013; 10(2):173-85. DOI: 10.1016/j.pdpdt.2012.08.003. View

17.

Arbour K, Riely G . Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. JAMA. 2019; 322(8):764-774. DOI: 10.1001/jama.2019.11058. View

18.

Shen J, Todd N, Zhang H, Yu L, Lingxiao X, Mei Y . Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest. 2010; 91(4):579-87. PMC: 3130190. DOI: 10.1038/labinvest.2010.194. View

19.

Kaibori M, Matsui K, Ishizaki M, Iida H, Sakaguchi T, Tsuda T . Evaluation of fluorescence imaging with indocyanine green in hepatocellular carcinoma. Cancer Imaging. 2016; 16:6. PMC: 4823845. DOI: 10.1186/s40644-016-0064-6. View

20.

Wang Y, Li J, Tong L, Zhang J, Zhai A, Xu K . The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol. 2013; 43(8):813-20. DOI: 10.1093/jjco/hyt084. View